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Background
Guanylyl cyclase-G (GC-G) is the last member of the recep-
tor GC family which has so far been identified. However,
the specific endogenous ligands, tissue distribution and
function of GC-G remain largely unknown. Our studies in
mice demonstrated by RT-PCR and immunohistochemistry
that GC-G mRNA and protein are expressed in the kidney,
specifically within renal tubular epithelial cells. To eluci-
date the renal functions of GC-G in vivo, we produced a new
genetic mouse model with targeted disruption of the GC-G
gene (GC-G-/-). Because increased expression of GC-G
mRNA was observed in response to ischemia-reperfusion
(I/R), we studied renal function of GC-G-/- mice and their
wild-type (WT) counterparts not only at baseline but also
after I/R.
Materials and methods
WT and GC-G-/- mice were subjected to bilateral renal artery
occlusion (45 min) followed by reperfusion (24 h). Mark-
ers for renal dysfunction, histopathology, apoptosis, and
inflammation were evaluated.
Results
Under normal conditions, no apparent renal histological
alterations were observed in GC-G-/- mice. However, I/R-
induced renal dsyfunction, as evident by the elevation of
serum creatinine and urea levels, was significantly attenu-
ated in GC-G-/- mice compared with WT mice. Furthermore,
genetic ablation of GC-G prevented tubular disruption,
tubular cell apoptosis, and caspase-3 activation, which was
accompanied by a marked reduction in neutrophil infiltra-
tion number, myeloperoxidase activity, or induction of
proinflammatory cytokine interleukin (IL)-6 and adhesion
molecule P-selectin in renal tissues under I/R in GC-G-/-
compared to levels seen in WT mice. In addition, gel mobil-
ity shift assay demonstrated that nuclear factor (NF)-κB-
promoter binding activity is markedly suppressed under
renal I/R in GC-G-deficient mice compared to WT controls.
Conclusion
Together, our study demonstrates for the first time that GC-
G may play critical apoptotic and inflammatory roles dur-
ing I/R-induced acute renal failure. This knockout mouse
provides an excellent model to further elucidate the signal-
ling pathway and the (patho)physiological functions medi-
ated by GC-G.
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